BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20621530)

  • 21. Piecewise hypersphere modeling by particle swarm optimization in QSAR studies of bioactivities of chemical compounds.
    Lin WQ; Jiang JH; Shen Q; Wu HL; Shen GL; Yu RQ
    J Chem Inf Model; 2005; 45(3):535-41. PubMed ID: 15921443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QSAR study on melanocortin-4 receptors by support vector machine.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    Eur J Med Chem; 2010 Mar; 45(3):1087-93. PubMed ID: 20031282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSAR analysis of cyclooxygenase inhibitor using particle swarm optimization and multiple linear regression.
    Lü JX; Shen Q; Jiang JH; Shen GL; Yu RQ
    J Pharm Biomed Anal; 2004 Jun; 35(4):679-87. PubMed ID: 15193712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
    Tung CW; Ho SY
    Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive configuring of radial basis function network by hybrid particle swarm algorithm for QSAR studies of organic compounds.
    Zhou YP; Jiang JH; Lin WQ; Zou HY; Wu HL; Shen GL; Yu RQ
    J Chem Inf Model; 2006; 46(6):2494-501. PubMed ID: 17125190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring QSARs for antiviral activity of 4-alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines by support vector machine.
    Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
    Chem Biol Drug Des; 2008 Sep; 72(3):205-16. PubMed ID: 18715229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
    Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
    J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacophore identification and bioactivity prediction for triaminotriazine derivatives by electron conformational-genetic algorithm QSAR method.
    Saripinar E; Geçen N; Sahin K; Yanmaz E
    Eur J Med Chem; 2010 Sep; 45(9):4157-68. PubMed ID: 20598401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico prediction of mitochondrial toxicity by using GA-CG-SVM approach.
    Zhang H; Chen QY; Xiang ML; Ma CY; Huang Q; Yang SY
    Toxicol In Vitro; 2009 Feb; 23(1):134-40. PubMed ID: 18940245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified ant colony optimization algorithm for variable selection in QSAR modeling: QSAR studies of cyclooxygenase inhibitors.
    Shen Q; Jiang JH; Tao JC; Shen GL; Yu RQ
    J Chem Inf Model; 2005; 45(4):1024-9. PubMed ID: 16045297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
    Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of retention times for a large set of pesticides or toxicants based on support vector machine and the heuristic method.
    Li X; Luan F; Si H; Hu Z; Liu M
    Toxicol Lett; 2007 Dec; 175(1-3):136-44. PubMed ID: 18024009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying P-glycoprotein substrates using a support vector machine optimized by a particle swarm.
    Huang J; Ma G; Muhammad I; Cheng Y
    J Chem Inf Model; 2007; 47(4):1638-47. PubMed ID: 17608407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method.
    Ma CY; Yang SY; Zhang H; Xiang ML; Huang Q; Wei YQ
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):677-82. PubMed ID: 18455346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR investigation of NaV1.7 active compounds using the SVM/Signature approach and the Bioclipse Modeling platform.
    Norinder U; Ek ME
    Bioorg Med Chem Lett; 2013 Jan; 23(1):261-3. PubMed ID: 23177785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HYPROSP II--a knowledge-based hybrid method for protein secondary structure prediction based on local prediction confidence.
    Lin HN; Chang JM; Wu KP; Sung TY; Hsu WL
    Bioinformatics; 2005 Aug; 21(15):3227-33. PubMed ID: 15932901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative prediction of logk of peptides in high-performance liquid chromatography based on molecular descriptors by using the heuristic method and support vector machine.
    Liu HX; Xue CX; Zhang RS; Yao XJ; Liu MC; Hu ZD; Fan BT
    J Chem Inf Comput Sci; 2004; 44(6):1979-86. PubMed ID: 15554667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR analysis of substituted bis[(acridine-4-carboxamide)propyl]methylamines using optimized block-wise variable combination by particle swarm optimization for partial least squares modeling.
    Lin L; Lin WQ; Jiang JH; Shen GL; Yu RQ
    Eur J Pharm Sci; 2005 Jun; 25(2-3):245-54. PubMed ID: 15911220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR models for phosphoramidate prodrugs of 2'-methylcytidine as inhibitors of hepatitis C virus based on PSO boosting.
    Cheng Z; Zhang Y; Zhou C
    Chem Biol Drug Des; 2011 Dec; 78(6):948-59. PubMed ID: 21895985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.